YARROW BIOSCIENCE, INC. Inventory Write-down
YARROW BIOSCIENCE, INC. (YARW) reported Inventory Write-down of $0 for the 0-month period ending 2022-01-12, per its 10-Q filed 2022-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2022-11-14
- YARROW BIOSCIENCE, INC. inventory write-down for the quarter ending 2021-12-31 was $0.00.
- YARROW BIOSCIENCE, INC. inventory write-down for the quarter ending 2021-09-30 was $0.00.
- YARROW BIOSCIENCE, INC. inventory write-down for the quarter ending 2021-06-30 was $0.00.
- YARROW BIOSCIENCE, INC. inventory write-down for the quarter ending 2021-03-31 was $0.00.
- YARROW BIOSCIENCE, INC. inventory write-down for fiscal 2020 was $0.00.
- YARROW BIOSCIENCE, INC. inventory write-down for fiscal 2019 was $0.00.
| Period end | Inventory Write-down 0 month | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|---|
| 2022-01-12 | $0.00 10-Q · filed 2022-11-14 | ||||
| 2021-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2022-05-12 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 derived: sum of 3 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-05-12 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | $0.00 derived: sum of 3 quarters · filed 2022-08-12 | $0.00 derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 | $0.00 derived: sum of 2 quarters · filed 2022-05-12 | $0.00 derived: sum of 3 quarters · filed 2022-05-12 | $0.00 derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $0.00 derived: sum of 2 quarters · filed 2022-03-17 | $0.00 derived: sum of 3 quarters · filed 2022-03-17 | $0.00 10-K · filed 2022-03-17 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2021-08-12 | $0.00 10-Q · filed 2020-11-05 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-06 | ||||
| 2019-12-31 | $0.00 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |